The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection

Chagas disease (CD), caused by the hemoflagellate protozoan Trypanosoma cruzi, affects more than six million people worldwide and presents an unsatisfactory therapy, based on two nitroderivatives, introduced in clinical medicine for decades. The synthetic peptide, with CTHRSSVVC sequence (PepA), mim...

Descripción completa

Detalles Bibliográficos
Autores principales: Leite, Gabriela Rodrigues, Batista, Denise da Gama Jaén, Mazzeti, Ana Lia, Silva, Rosemeire Aparecida, Lugão, Ademar Benévolo, Soeiro, Maria de Nazaré Correia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121062/
https://www.ncbi.nlm.nih.gov/pubmed/35601101
http://dx.doi.org/10.3389/fcimb.2022.882555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121062/
https://www.ncbi.nlm.nih.gov/pubmed/35601101
http://dx.doi.org/10.3389/fcimb.2022.882555

Ejemplares similares